Ceftaroline-Associated Encephalopathy: A Rare Adverse Effect

Aswin Srinivasan; Blake Bennie; Krina Viroliya; Ramesh Kesavan; Siva Sarva

Ceftaroline-Associated Encephalopathy: A Rare Adverse Effect

Aswin Srinivasan
, Blake Bennie
, Krina Viroliya
, Ramesh Kesavan
, Siva Sarva

HCA Houston Healthcare Kingwood

HCA Healthcare

Research output: Contribution to journal › Article › peer-review

Abstract

In this case report, we present a patient who suffered ceftaroline-associated encephalopathy, while receiving ceftaroline for acute bacterial skin and skin structure infections (aBSSSIs) that resolved after cessation of the suspected agent. We recommend close monitoring for encephalopathy in patients with creatinine clearance (CrCl) of <50 mL/min receiving ceftaroline.

Original language	American English
Journal	Internal Medicine
State	Published - May 1 2021

Keywords

ceftaroline
encephalopathy
drug-related side effects and adverse reactions

Disciplines

Diseases
Internal Medicine
Nervous System Diseases

Access to Document

https://doi.org/10.7759/cureus.14795

Cite this

@article{2100a2e395204be0ae9b94d88f897930,

title = "Ceftaroline-Associated Encephalopathy: A Rare Adverse Effect",

abstract = " In this case report, we present a patient who suffered ceftaroline-associated encephalopathy, while receiving ceftaroline for acute bacterial skin and skin structure infections (aBSSSIs) that resolved after cessation of the suspected agent. We recommend close monitoring for encephalopathy in patients with creatinine clearance (CrCl) of <50 mL/min receiving ceftaroline.",

keywords = "ceftaroline, encephalopathy, drug-related side effects and adverse reactions",

author = "Aswin Srinivasan and Blake Bennie and Krina Viroliya and Ramesh Kesavan and Siva Sarva",

note = "Srinivasan A, Bennie B, Viroliya K, Kesavan R, Sarva ST. Ceftaroline-Associated Encephalopathy: A Rare Adverse Effect. Cureus. 2021;13(5):e14795. doi: 10.7759/cureus.14795",

year = "2021",

month = may,

day = "1",

language = "American English",

journal = "Internal Medicine",

}

TY - JOUR

T1 - Ceftaroline-Associated Encephalopathy: A Rare Adverse Effect

AU - Srinivasan, Aswin

AU - Bennie, Blake

AU - Viroliya, Krina

AU - Kesavan, Ramesh

AU - Sarva, Siva

N1 - Srinivasan A, Bennie B, Viroliya K, Kesavan R, Sarva ST. Ceftaroline-Associated Encephalopathy: A Rare Adverse Effect. Cureus. 2021;13(5):e14795. doi: 10.7759/cureus.14795

PY - 2021/5/1

Y1 - 2021/5/1

N2 - In this case report, we present a patient who suffered ceftaroline-associated encephalopathy, while receiving ceftaroline for acute bacterial skin and skin structure infections (aBSSSIs) that resolved after cessation of the suspected agent. We recommend close monitoring for encephalopathy in patients with creatinine clearance (CrCl) of <50 mL/min receiving ceftaroline.

AB - In this case report, we present a patient who suffered ceftaroline-associated encephalopathy, while receiving ceftaroline for acute bacterial skin and skin structure infections (aBSSSIs) that resolved after cessation of the suspected agent. We recommend close monitoring for encephalopathy in patients with creatinine clearance (CrCl) of <50 mL/min receiving ceftaroline.

KW - ceftaroline

KW - encephalopathy

KW - drug-related side effects and adverse reactions

UR - https://scholarlycommons.hcahealthcare.com/internal-medicine/167

UR - https://doi.org/10.7759/cureus.14795

M3 - Article

JO - Internal Medicine

JF - Internal Medicine

ER -

Ceftaroline-Associated Encephalopathy: A Rare Adverse Effect

Abstract

Keywords

Disciplines

Access to Document

Other files and links

Cite this